The National Biosafety Authority (NBA) of Kenya is set to convene the NBA International Scientific Conference 2027 from February 1-4, 2027, in Nairobi. This conference aims to bring together scientists, policymakers, biosafety regulators, researchers, industry representatives, development partners, the media, and other stakeholders. The goal is to advance responsible biotechnology innovation for sustainable development, focusing on safe biotechnology applications in agriculture, health, and the environment.
The conference, themed 'From Innovation to Impact: Advancing Safe Biotechnology through Regional Collaboration, Regulatory Excellence and Knowledge Partnerships for Sustainable Agriculture, Health and Environment', will provide a platform for knowledge exchange and scientific dialogue. It seeks to strengthen biosafety oversight and build partnerships to support the responsible application of biotechnology. With advances in modern biotechnology creating new opportunities and regulatory considerations, discussions will focus on scientific innovation, effective regulation, and regional cooperation.
The four-day conference will explore key areas, including modern biotechnology for food security and economic growth, emerging biotechnologies and regulatory preparedness, and regional harmonization of biosafety systems. Additionally, participants will examine climate resilience, biodiversity, and environmental stewardship, as well as partnerships and financing for biotechnology development. The role of science communication, public participation, and stakeholder engagement in strengthening public understanding of biotechnology will also be discussed.
The conference will provide a platform for examining emerging technologies, including genome editing, CRISPR-based tools, gene drives, digital and synthetic biology, and the application of artificial intelligence in biotechnology research. Discussions will consider the implications of these developments for risk assessment, regulatory preparedness, and governance. Regional cooperation will be another key focus, with participants examining opportunities for harmonizing biosafety regulatory systems and sharing scientific and regulatory information.
According to NBA Board Chairman Mr. David Wamatsi, the conference will strengthen collaboration among scientists, regulators, policymakers, and industry. He emphasized that bringing these stakeholders together will advance informed dialogue on safe biotechnology and explore ways scientific innovation can contribute to sustainable development. NBA Acting Chief Executive Officer Dr. Ann Karimi noted that biotechnology continues to evolve, and effective biosafety oversight, scientific evidence, and institutional preparedness are essential.
The conference will feature keynote addresses, technical sessions, panel discussions, poster presentations, exhibitions, and high-level policy dialogue. A dedicated session on partnerships and financing will discuss investment, capacity-building, and collaborative approaches to strengthening Africa's biotechnology ecosystem. The conference will also emphasize public trust and inclusive stakeholder engagement, with discussions on effective science communication and responsible media engagement.
Ultimately, the conference aims to strengthen national, regional, and international partnerships, promote evidence-informed discussions, and contribute to stronger biosafety systems that support sustainable development. The National Biosafety Authority invites scientists, researchers, policymakers, regulators, universities, industry players, development partners, farmers, civil society organizations, and media practitioners to participate and contribute to discussions shaping the future of safe biotechnology in Africa and beyond.
Key points
- The conference will focus on regional cooperation and harmonization of biosafety regulatory systems.
- The event aims to strengthen collaboration among scientists, regulators, policymakers, and industry.
- The conference will discuss emerging technologies, including genome editing and artificial intelligence in biotechnology research.
